Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
S&P Pharmaceuticals SPDR (NY: XPH)
43.33 USD  +0.00 (+0.00%)
Official Closing Price  /  Updated: 4:10 PM EDT, Jul 10, 2020  /  Add to My Watchlist      
View: Quote News
Fund Overview
S&P Pharmaceuticals SPDR
Sector
Exchange Traded NY
Net Assets 331.49M
Inception Date
Related Funds
Quote
Price 43.33
Volume 26,080
Last Trade Jul 10, 4:10pm
Change (%)
+0.00 (0.00%)
Prev. Close 43.33
YTD %
-4.87%
Dividend Yield 0.56%
Performance
YTD
-2.22 (-4.87%)
1 Month
-0.50 (-1.14%)
3 Month
+5.06 (13.22%)
6 Month
-1.59 (-3.54%)
1 Year
+4.02 (10.23%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
3 Reasons to Buy Eli Lilly Stock
Eli Lilly has been outperforming — and could continue to outperform — the market. Read More
from Motley Fool
Expect Pharma M&A to Rebound After COVID-19 Eases
The pharmaceutical industry is often a hotbed of takeover rumors. Some experts believe that speculation and deals themselves could heat up again after the coronavirus outbreak subsides, potentially... Read More
from ETFdb
Top News
More News
Expect Pharmaceuticals M&A Activity to Rebound After COVID-19 Eases
The pharmaceutical industry is often a hotbed of takeover rumors. Some experts believe that speculation and deals themselves could heat up again after the coronavirus outbreak subsides, potentially... Read More
from ETF Trends
Pharma ETFs Gain On Healthy Q4 Earnings
Strong results led to solid trading in pharma ETFs over the past week. Here they are in detail. Read More
from Blogs - TalkMarkets
Could A More Significant Volatility Breakout Be Underway?
In a market that has been steadily climbing despite impeachment proceedings against President Trump, a roller-coaster ride due to tariffs and a trade war with China, and generalized global uncertainty,... Read More
from ETF Trends
A Look at the S&P Sectors from 2019
By Canterbury Investment Management Market State 1 (Bullish) – The S&P 500 continues its run in Market State 1, now at 14 consecutive days. Many equity assets experienced a nice little move to end... Read More
from ETF Trends
How The Parts Add Up: XPH Headed For $54
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... Read More
from ETF Channel
XPH's Holdings Could Mean 17% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... Read More
from ETF Channel
Best & Worst Monthly Performers: December 18 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
Is Coiled Volatility Suggesting Big Stock Move?
Options bets suggest that traders may be a bit too unnerved about the risks facing the stock market heading into the end of the year. History suggests that such complacency could come back to bite... Read More
from ETFdb
Markets Bounce Back & Close Week Near Record Highs
U.S. markets closed near record highs for the week, with the Dow Jones Industrial Average up 1.1% week to date, and the S&P 500 and Nasdaq Composite gathering 0.6% and 0.8%, respectively, for the week.... Read More
from ETFdb
Could Coiled Volatility Suggest A Bigger Stock Move Is Coming?
Options bets suggest that traders may be a bit too unnerved about the risks facing the stock market heading into the end of the year. History suggests that such complacency could come back to bite... Read More
from ETF Trends
Markets Bounce Back to Close Week Near Record Highs
U.S. markets closed near record highs for the week, with the Dow Jones Industrial Average up 1.1% week to date, and the S&P 500 and Nasdaq Composite gathering 0.6% and 0.8%, respectively, for the week.... Read More
from ETF Trends
Pharma ETFs Set To Benefit Post Strong Q3 Earnings
Robust results led to solid trading in pharma ETFs in a month. Here they are in detail. Read More
from Blogs - TalkMarkets
Attractive Market Opportunities
Investors can buy the market as it hits new highs using passive mutual funds or ETFs, or if they don’t want to chase strength they can look to the healthcare sector. There are opportunities for... Read More
from Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.